Department of Finance Annual Report 2023-2024
This publication is the Annual Report for the Department of Finance for the fiscal year ending March 31, 2024.
for "annual statistical//////////////////"
This publication is the Annual Report for the Department of Finance for the fiscal year ending March 31, 2024.
This is a statistical report on Colorectal Cancer in Prince Edward Island. It is one report in a series that is being developed to provide a meaningful look at the four most frequently diagnosed cancers in PEI (lung, colorectal, breast and prostate cancers).
L’Annual Statistical Review (rapport statistique annuel) révèle que 2017 a été une année record pour l'Île-du-Prince-Édouard pour ce qui est de la démographie, de la composition sociale et de l’économie. « Cet instantané annuel aide les gouvernements et les entreprises à...
This publication is the Annual Report for the Department of Finance for the fiscal year ending March 31, 2023.
2020-2021 – Annual Report Office of the Public Guardian Official Guardian and Public Trustee
This is a statistical report on Prostate Cancer in Prince Edward Island. It is one report in a series that is being developed to provide a meaningful look at the four most frequently diagnosed cancers in PEI (lung, colorectal, breast and prostate cancers).
La 50e édition du Annual Statistical Review (rapport statistique annuel) atteste que l’Île-du-Prince-Édouard a toujours la croissance économique la plus rapide parmi les provinces, se classant au second rang derrière le territoire du Nunavut, malgré le ralentissement de l...
This is a statistical report on Breast Cancer in Prince Edward Island. It is one report in a series that is being developed to provide a meaningful look at the four most frequently diagnosed cancers in PEI (lung, colorectal, breast and prostate cancers).
This is a statistical report on Lung Cancer in Prince Edward Island. It is one report in a series that is being developed to provide a meaningful look at the four most frequently diagnosed cancers in PEI (lung, colorectal, breast and prostate cancers).